×
Entrez Id:
5604
Gene Symbol:
MAP2K1
MAP2K1
melanoma
0.700
CausalMutation
CLINVAR
Novel ATP-competitive MEK inhibitor E6201 is effective against vemurafenib-resistant melanoma harboring the MEK1-C121S mutation in a preclinical model.
24448821
2014
×
Entrez Id:
5604
Gene Symbol:
MAP2K1
MAP2K1
melanoma
0.700
GeneticVariation
CLINVAR
Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
25157968
2014
×
Entrez Id:
5604
Gene Symbol:
MAP2K1
MAP2K1
melanoma
0.700
CausalMutation
CLINVAR
Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
25157968
2014
×
Entrez Id:
5604
Gene Symbol:
MAP2K1
MAP2K1
melanoma
0.700
GeneticVariation
CLINVAR
Phase II trial of MEK inhibitor selumetinib (AZD6244, ARRY-142886) in patients with BRAFV600E/K-mutated melanoma.
23444215
2013
×
Entrez Id:
5604
Gene Symbol:
MAP2K1
MAP2K1
melanoma
0.700
GeneticVariation
CLINVAR
Pharmacodynamic effects and mechanisms of resistance to vemurafenib in patients with metastatic melanoma.
23569304
2013
×
Entrez Id:
5604
Gene Symbol:
MAP2K1
MAP2K1
melanoma
0.700
CausalMutation
CLINVAR
Pharmacodynamic effects and mechanisms of resistance to vemurafenib in patients with metastatic melanoma.
23569304
2013
×
Entrez Id:
5604
Gene Symbol:
MAP2K1
MAP2K1
melanoma
0.700
GeneticVariation
CLINVAR
Discovery of a novel ERK inhibitor with activity in models of acquired resistance to BRAF and MEK inhibitors.
23614898
2013
×
Entrez Id:
5604
Gene Symbol:
MAP2K1
MAP2K1
melanoma
0.700
CausalMutation
CLINVAR
Preexisting MEK1 exon 3 mutations in V600E/KBRAF melanomas do not confer resistance to BRAF inhibitors.
22588879
2012
×
Entrez Id:
5604
Gene Symbol:
MAP2K1
MAP2K1
melanoma
0.700
CausalMutation
CLINVAR
Melanoma genome sequencing reveals frequent PREX2 mutations.
22622578
2012
×
Entrez Id:
5604
Gene Symbol:
MAP2K1
MAP2K1
melanoma
0.700
CausalMutation
CLINVAR
Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling.
21383288
2011
×
Entrez Id:
5604
Gene Symbol:
MAP2K1
MAP2K1
melanoma
0.700
CausalMutation
CLINVAR
Screening a larger cohort of individuals with melanoma revealed the presence of recurring somatic MAP2K1 and MAP2K2 mutations, which occurred at an overall frequency of 8%.
22197931
2011
×
Entrez Id:
5604
Gene Symbol:
MAP2K1
MAP2K1
melanoma
0.700
CausalMutation
CLINVAR
COT drives resistance to RAF inhibition through MAP kinase pathway reactivation.
21107320
2010
×
Entrez Id:
5604
Gene Symbol:
MAP2K1
MAP2K1
melanoma
0.700
GeneticVariation
CLINVAR
MEK1 mutations confer resistance to MEK and B-RAF inhibition.
19915144
2009
×
Entrez Id:
5604
Gene Symbol:
MAP2K1
MAP2K1
melanoma
0.700
CausalMutation
CLINVAR
MEK1 mutations confer resistance to MEK and B-RAF inhibition.
19915144
2009